Log in
  • Home
  • DSUVIATM (sufentanil): The First Sublingual Formulation of Sufentanil

DSUVIATM (sufentanil): The First Sublingual Formulation of Sufentanil

  • Wednesday, November 06, 2019
  • 6:00 PM
  • Firebirds Wood Fired Grill, 1225 Churchman's Road, Newark, DE 19713

DSUVIATM (sufentanil):
The First Sublingual Formulation of Sufentanil

For patients with acute pain severe enough to require an opioid, DSUVIA offers a noninvasive option when opioids are needed in a medically supervised setting.  

You're invited to learn more about DSUVIA, the first sublingual formulation of sufentanil.  This program will cover the:

  • Clinical opportunity for noninvasive opioid analgesic
  • Noninvasive sublingual administration of DSUVIA
  • Pharmacokinetics and pharmacodynamics of the single, fixed-dose DSUVIA
  • Demonstrated efficacy and safety of DSUVIA in adults with moderate-to-severe acute pain

For additional information regarding this event, please contact Catherine Alto at 703-217-4178 or calto@acelrx.com.


Please register online here: http://www.acelrxprograms.com

Registration Code: 12129SR75

Click here to download the full invitation.


Copyright 2017 - Delaware Association of Nurse Anesthetists (DANA)

Powered by Wild Apricot Membership Software